Shared Decision Making for Patients With First-admission Schizophrenia
Phase 2
Completed
- Conditions
- Schizophrenia
- Interventions
- Behavioral: Shared Decision Making
- Registration Number
- NCT01869660
- Lead Sponsor
- Yokohama City University
- Brief Summary
To determine whether shared decision making (SDM) intervention improves patient satisfaction in patients with first-admission schizophrenia compared with usual care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
- Admitted to an acute care psychiatric ward.
- Diagnosed with schizophrenia (ICD-10 codes: F20-F29)
- Aged 16 to 65 years old at admission
- No prior experience of psychiatric admission (first-admission)
Exclusion Criteria
- Diagnosed with moderate to severe mental retardation
- Diagnosed with organic mental disorders (ICD10 codes: F00-F09)
- Having poor Japanese language skill
- Severe conceptual disorganization as measured by brief psychiatric rating scale of 5 or more.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Shared Decision Making Shared Decision Making The present SDM intervention is based on principles derived from previous randomized controlled trials of SDMs. SDM meetings comprise at least 4 weekly 20 minutes sessions. Meetings have at least three professionals: a case manager (psychiatrists or nurses), a primary doctor, and a nurse/social worker. The focus of the meeting is to empower patients to discuss their attitudes and preferences toward treatments.
- Primary Outcome Measures
Name Time Method Patient satisfaction as measured by the Japanese version of the Client Satisfaction Questionnaire (CSQ-8) Within 7days before the date of discharge
- Secondary Outcome Measures
Name Time Method Attitude toward medication as measured by the Japanese version of the Drug Attitude Inventory (DAI-10) Within 7days before the date of discharge Treatment continuation as measured by the rate of outpatient attendance during the 30 days 6 months after discharge
Trial Locations
- Locations (1)
Numazu Chuou Hospital
🇯🇵Numazu, Shizuoka, Japan